Your browser doesn't support javascript.
loading
Molecular conservation and Differential mutation on ORF3a gene in Indian SARS-CoV2 genomes
Sk. Sarif Hassan; Pabitra Pal Choudhury; Pallab Basu; Siddhartha Sankar Jana.
Afiliação
  • Sk. Sarif Hassan; Department of Mathematics, Pingla Thana Mahavidyalaya
  • Pabitra Pal Choudhury; Applied Statistics Unit, Indian Statistical Institute, Kolkata
  • Pallab Basu; Mandelstem Institute, School of Physics, University of the Witwatersrand, Johannesburg, South Africa
  • Siddhartha Sankar Jana; School of Biological Sciences, Indian Association for the Cultivation of Science, Kolkata
Preprint em Inglês | bioRxiv | ID: ppbiorxiv-096107
Artigo de periódico
Um artigo publicado em periódico científico está disponível e provavelmente é baseado neste preprint, por meio do reconhecimento de similaridade realizado por uma máquina. A confirmação humana ainda está pendente.
Ver artigo de periódico
ABSTRACT
A global emergency due to the COVID-19 pandemic demands various studies related to genes and genomes of the SARS-CoV2. Among other important proteins, the role of accessory proteins are of immense importance in replication, regulation of infections of the coronavirus in the hosts. The largest accessory proteins in the SARS-CoV2 genome is ORF3a which modulates the host response to the virus infection and consequently it plays an important role in pathogenesis. In this study, an attempt is made to decipher the conservation of nucleotides, dimers, codons and amino acids in the ORF3a genes across thirty two genomes of Indian patients. ORF3a gene possesses single and double point mutations in Indian SARS-CoV2 genomes suggesting the change of SARS-CoV2s virulence property in Indian patients. We find that the parental origin of the ORF3a gene over the genomes of SARS-CoV2 and Pangolin-CoV is same from the phylogenetic analysis based on conservations of nucleotides and so on. This study highlights the accumulation of mutation on ORF3a in Indian SARS-CoV2 genomes which may provide the designing therapeutic approach against SARS-CoV2.
Licença
cc_by_nd
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
Texto completo: Disponível Coleções: Preprints Base de dados: bioRxiv Idioma: Inglês Ano de publicação: 2020 Tipo de documento: Preprint
...